Nektar Therapeutics | NKTR - Operating Profit


Nektar Therapeutics reported $-19.09M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Agios Pharmaceuticals USD -110.02M 11.55M Mar/2026
ALKERMES USD -48.28M 37.33M Mar/2026
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Amgen USD 3.83B 130M Mar/2026
Baxter International USD 66M 280.2M Mar/2026
BioCryst Pharmaceuticals USD 260.38M 230.79M Dec/2025
Biogen USD 514.3M 128.8M Mar/2026
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Cara Therapeutics USD -5.94M 3.55M Sep/2025
Cipla INR 6.14B 3.63B Mar/2026
Dr.Reddys Laboratories INR 888M 13.05B Mar/2026
Eisai JPY -10.31B 30.35B Mar/2026
Eli Lilly USD 9.78B 792M Mar/2026
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Exelixis USD 251.34M 15.43M Mar/2026
Gilead Sciences USD 2.68B 284M Mar/2026
GlaxoSmithKline GBP 2.29B 856M Mar/2026
Grifols EUR 320.55M 91.01M Dec/2025
Halozyme Therapeutics USD -61.77M 26.64M Mar/2026
Incyte USD 324.17M 59.7M Mar/2026
Ionis Pharmaceuticals USD -118M 97M Mar/2026
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
Karyopharm Therapeutics USD -17.84M 13.44M Dec/2025
MacroGenics USD -12.1M 30.74M Dec/2025
Merck USD -1.88B 8.12B Mar/2026
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Neurocrine Biosciences USD 214.6M 13.3M Mar/2026
Novartis USD 4.24B 171M Mar/2026
Pfizer USD 4.99B 340M Mar/2026
Roche Holding CHF 9.56B 3.8B Dec/2025
Sarepta Therapeutics USD 358.43M 768.52M Mar/2026
Takeda JPY -13.62B 182.44B Mar/2026
Teva Pharmaceutical Industries USD 758M 271M Mar/2026
Xencor USD -77.86M 24.23M Mar/2026